Blood Irradiation Indicators and Labels

Blood Irradiation Indicators and Labels Market Outlook

The global blood irradiation indicators and labels market is projected to reach approximately USD 1.2 billion by 2035, growing at a CAGR of about 6.5% from 2025 to 2035. This growth is primarily driven by the increasing demand for safe blood transfusions, advancements in blood irradiation technology, and the rising prevalence of blood-borne diseases. The growing number of blood banks and hospitals, coupled with stringent regulatory standards for blood safety, further enhances the market's potential. Furthermore, innovations in radiation-sensitive materials and the development of advanced biological indicators and labels are expected to propel market growth as healthcare institutions prioritize patient safety and effective blood management.

Growth Factor of the Market

The blood irradiation indicators and labels market is experiencing significant growth due to several factors impacting the healthcare sector. One of the primary growth drivers is the rising incidence of transfusion-transmissible infections, which has led to heightened awareness and adoption of blood safety measures. Moreover, regulatory bodies are enforcing strict guidelines to ensure the safety of blood products, further stimulating the demand for reliable blood irradiation solutions. The technological advancements in irradiation processes and the development of effective labeling systems are also contributing to market growth. Additionally, the increasing number of blood donations and the expansion of healthcare infrastructure in emerging economies are opening new avenues for market players. The integration of digital technologies in monitoring and labeling blood products is anticipated to enhance operational efficiency and safety.

Key Highlights of the Market

• The blood irradiation indicators and labels market is expected to witness a CAGR of 6.5% between 2025 and 2035.
• North America holds the largest market share due to advanced healthcare facilities and stringent regulatory frameworks.
• Biological indicators are anticipated to dominate the product type segment owing to their effectiveness in ensuring blood safety.
• Blood banks are projected to be the leading application segment, driven by increasing blood donation initiatives.
• The rising adoption of online distribution channels is reshaping the market landscape, making products more accessible.

By Product Type

Chemical Indicators:

Chemical indicators play a crucial role in the blood irradiation indicators and labels market by providing a visual representation of the exposure of blood components to radiation. These indicators change color when subjected to specific radiological conditions, ensuring that blood products have undergone adequate irradiation for safety. Their use is prevalent in hospitals and blood banks, where monitoring is vital for maintaining safety standards. The simplicity of application and cost-effectiveness of chemical indicators makes them a preferred choice among healthcare professionals. With the rising focus on patient safety, the demand for these indicators is expected to increase significantly in the coming years, driving market growth.

Biological Indicators:

Biological indicators consist of living microorganisms that are subjected to radiation exposure, providing a benchmark for assessing the efficacy of the irradiation process. This type of indicator is critical in ensuring that sufficient radiation has been delivered to eliminate potential pathogens from blood products. The reliability and accuracy of biological indicators in monitoring blood safety have made them indispensable in the blood irradiation process. As regulations regarding blood safety become more stringent, the adoption of biological indicators is expected to rise, contributing substantially to the market's growth. Their capacity to detect over-irradiation also enhances their appeal, positioning them favorably within the market.

Radiochromic Labels:

Radiochromic labels are sophisticated components used to provide a direct visual indication of radiation dose levels. These labels change color in response to radiation exposure, allowing healthcare providers to quickly assess whether blood products have received adequate treatment. Their precision and clarity make them an attractive option for blood banks and hospitals, as they enhance the overall safety of blood transfusions. As the demand for standardized blood irradiation practices increases, radiochromic labels are likely to gain traction in the market. The ability to customize these labels for specific applications and their ease of integration into existing systems further solidify their market position, promising significant growth opportunities.

Thermochromic Labels:

Thermochromic labels are innovative products that change color in response to temperature fluctuations, providing an additional layer of monitoring for blood products. These labels are particularly useful in ensuring that blood components are stored and transported within recommended temperature ranges, which is critical for maintaining their viability. The application of thermochromic technology in the blood irradiation process aligns with the growing emphasis on optimal blood management practices. As healthcare facilities increasingly adopt comprehensive solutions for blood safety, the demand for thermochromic labels is expected to grow, contributing positively to the market landscape.

Biological Labels:

Biological labels are designed to provide vital information regarding the biological characteristics of blood products, such as expiration dates and storage conditions. These labels facilitate efficient tracking and management of blood components, ensuring that healthcare providers have access to essential information at all times. With the rising focus on traceability in healthcare, the demand for biological labels is anticipated to escalate, thereby enhancing market growth. Moreover, advances in labeling technologies are expected to improve the accuracy and durability of biological labels, making them an integral part of blood irradiation systems in hospitals and blood banks.

By Application

Blood Banks:

Blood banks represent a significant segment in the blood irradiation indicators and labels market due to their critical role in blood collection, testing, and storage. The implementation of rigorous safety measures necessitates the use of effective indicators and labels to monitor the safety and viability of blood products. As blood donation drives increase and awareness of blood safety grows, blood banks are investing in advanced irradiation solutions to ensure the highest standards of safety. This ongoing trend is expected to propel the demand for blood irradiation indicators and labels significantly in this sector, fostering market expansion.

Hospitals:

Hospitals are pivotal players in the blood irradiation indicators and labels market, as they are the primary users of irradiated blood products for transfusions. The increasing number of surgeries and medical procedures requiring blood transfusions is driving the demand for reliable blood irradiation practices. Hospitals are adopting advanced technologies for blood management, focusing on maintaining the safety and efficacy of transfused products. The growing emphasis on patient safety and compliance with healthcare regulations is leading to increased adoption of indicators and labels, positioning hospitals as a key application segment in the market.

Pharmaceutical Companies:

Pharmaceutical companies also play a crucial role in the blood irradiation indicators and labels market, especially those involved in developing blood-related therapies and products. The need for stringent safety measures in the production and distribution of blood-derived pharmaceuticals necessitates the use of effective irradiation indicators and labels. As pharmaceutical companies strive to ensure the safety of their products, the adoption of advanced blood irradiation solutions is expected to rise, driving market growth. Furthermore, collaborations between pharmaceutical companies and healthcare facilities to enhance blood safety protocols will further strengthen this segment's position in the market.

Research Institutes:

Research institutes are increasingly utilizing blood irradiation indicators and labels in various studies focused on blood safety and transfusion practices. The need for accurate monitoring of irradiation processes in experimental setups drives the demand for reliable indicators and labels. As research in transfusion medicine advances and the understanding of blood safety deepens, research institutes are expected to adopt innovative technologies to enhance their protocols. The growing emphasis on evidence-based practices in healthcare is likely to contribute to increased investment in blood irradiation solutions within research settings, thereby fostering market growth.

Others:

The "Others" segment encompasses a variety of applications, including educational institutions, veterinary clinics, and emergency services, which also require blood irradiation indicators and labels. As awareness of blood safety increases across diverse sectors, this segment is expected to witness significant growth. The integration of blood irradiation practices in non-traditional settings highlights the versatility of indicators and labels, showcasing their importance beyond conventional healthcare environments. This ongoing trend is likely to create new opportunities for market players, further diversifying the blood irradiation indicators and labels market.

By Distribution Channel

Online Stores:

Online stores are rapidly gaining popularity as a distribution channel for blood irradiation indicators and labels. The convenience of online shopping, coupled with a wide range of product offerings, allows customers to access essential products efficiently. The growth of e-commerce platforms has made it easier for healthcare institutions to procure irradiation solutions at competitive prices. As more healthcare providers embrace digital solutions, the online channel is expected to expand significantly, driving market growth. Additionally, the ability to compare products and read reviews online enhances the purchasing process, making it an attractive option for buyers.

Hospitals/Clinics:

Hospitals and clinics represent a traditional yet vital distribution channel for blood irradiation indicators and labels. These facilities require immediate access to reliable products to ensure patient safety during blood transfusions. Establishing partnerships with suppliers who can offer timely delivery and support is essential in this segment. The increasing focus on maintaining high-quality standards in medical facilities is leading to greater investments in blood irradiation solutions, thus bolstering this distribution channel's growth. As hospitals prioritize the availability of safe blood products, collaboration with trusted distributors will continue to play a crucial role in this market segment.

Specialty Stores:

Specialty stores provide a more personalized shopping experience for healthcare professionals seeking specific blood irradiation indicators and labels. These stores often carry a curated selection of high-quality products, allowing customers to find specialized items tailored to their needs. The expertise of staff in specialty stores can provide valuable insights to healthcare providers, ensuring they select the most suitable products for their applications. Although this distribution channel may not have the same reach as online stores, it remains significant for customers seeking expert guidance and specialized offerings. The emphasis on quality and service in specialty stores is expected to support their growth in the market.

Others:

The "Others" distribution channel includes various avenues such as wholesalers, direct sales by manufacturers, and trade shows. In this segment, wholesalers play a crucial role in bridging the gap between manufacturers and end-users, ensuring that products reach healthcare institutions promptly. Direct sales from manufacturers provide an opportunity for healthcare providers to negotiate pricing and establish long-term relationships. Trade shows also facilitate networking and product showcasing, enabling market players to connect with potential clients. As these alternative distribution channels increasingly evolve, they will contribute to market expansion by improving access to blood irradiation indicators and labels.

By Ingredient Type

Radiation-Sensitive Materials:

Radiation-sensitive materials are fundamental components in the production of blood irradiation indicators and labels. These materials react to specific radiation doses, providing vital information regarding the exposure levels of blood products. The development of advanced radiation-sensitive materials has led to improved accuracy and reliability in monitoring irradiation processes. As healthcare institutions increasingly prioritize blood safety, the demand for high-quality radiation-sensitive materials is expected to grow. The ongoing research into developing new materials with enhanced properties will further bolster this segment, ensuring that it remains a key driver in the blood irradiation indicators and labels market.

Biological Materials:

Biological materials are essential for the production of biological indicators used in assessing the efficacy of blood irradiation processes. These materials contain live microorganisms that provide a benchmark for evaluating the safety of blood products. The growing awareness of the importance of biological indicators in ensuring blood safety is driving the demand for high-quality biological materials. As industry regulations become more stringent, the emphasis on using reliable biological materials will continue to rise, fostering growth in this segment. The research and development of innovative biological materials that can withstand various conditions will play a crucial role in enhancing the overall efficacy of blood irradiation systems.

Adhesive Materials:

Adhesive materials play a vital role in the production of blood irradiation indicators and labels, as they ensure the durability and functionality of these products. The efficacy of adhesive materials is critical to maintaining the integrity of labels and indicators during storage and handling. As the demand for high-performance adhesive materials increases, manufacturers are focusing on developing products that can withstand various environmental conditions while ensuring optimal performance. The growing emphasis on quality control in healthcare environments is leading to increased investments in adhesive materials, contributing significantly to the blood irradiation indicators and labels market.

Printing Materials:

Printing materials are crucial for creating high-quality labels and indicators that provide essential information regarding blood products. The quality of printing materials directly impacts the visibility and readability of labels, making it imperative for manufacturers to utilize high-grade materials. As technology advances, printing materials have evolved to offer improved durability and resistance to various environmental factors. The increasing importance of accurate labeling in healthcare is driving the demand for superior printing materials. Consequently, manufacturers are investing in research and development to enhance the performance of printing materials, ensuring they meet the expectations of healthcare providers.

Packaging Materials:

Packaging materials are essential for safeguarding blood irradiation indicators and labels during storage and transportation. The integrity of these materials ensures that the products remain uncontaminated and functional until they are used. With the rising focus on sustainability, manufacturers are exploring eco-friendly packaging options that align with healthcare institutions’ environmental goals. The demand for reliable packaging materials is expected to grow as healthcare facilities prioritize the safe handling of blood products. Innovations in packaging technologies aimed at improving the shelf life and usability of blood irradiation indicators and labels will play a significant role in advancing this segment within the market.

By Region

The North American region holds the largest share in the blood irradiation indicators and labels market, driven by advanced healthcare infrastructure and strict regulatory frameworks governing blood safety. The presence of leading healthcare institutions and increased expenditure on medical technologies further bolster market growth in this region. The United States, in particular, accounts for a significant portion of the market, with substantial investments in blood management and safety initiatives. The CAGR for this region is expected to remain strong as hospitals and blood banks continue to prioritize the effective monitoring of blood products. Additionally, the growing awareness and adoption of advanced blood irradiation practices among healthcare professionals will contribute to North America's market dominance.

Europe follows closely behind as a key player in the blood irradiation indicators and labels market. The region benefits from a well-established healthcare system and rigorous regulations aimed at ensuring blood safety. The increasing number of blood donation initiatives and awareness campaigns regarding transfusion-transmissible infections further drive the demand for reliable blood irradiation solutions. Countries such as Germany, France, and the UK are at the forefront of implementing advanced blood safety measures, contributing to the overall growth of the market. As healthcare providers in Europe emphasize the importance of patient safety, the adoption of blood irradiation indicators and labels is expected to witness significant growth, further enhancing the region's market presence.

Opportunities

The blood irradiation indicators and labels market presents numerous opportunities for growth, particularly with the increasing focus on patient safety and the growing awareness of transfusion-transmissible infections. As healthcare facilities continue to adopt advanced technologies to enhance blood safety protocols, market players can capitalize on the demand for innovative blood irradiation solutions. The integration of digital technologies, such as real-time monitoring and tracking systems, into blood management practices is expected to create new avenues for market expansion. Additionally, the growing number of blood donation campaigns and initiatives worldwide presents an opportunity for market players to develop tailored solutions that cater to the unique needs of blood banks and hospitals.

Moreover, emerging economies present a significant opportunity for growth in the blood irradiation indicators and labels market. As healthcare infrastructure continues to improve in these regions, there is an increasing need for reliable blood safety solutions. The expansion of healthcare services and the rising prevalence of blood-borne diseases will likely drive demand for blood irradiation indicators and labels. Companies that focus on establishing strong distribution networks and partnerships in these regions can effectively tap into this growing market. Furthermore, developing eco-friendly and sustainable products aligns with the global shift towards environmentally responsible practices, providing an additional opportunity for market players to differentiate themselves and capture market share.

Threats

Despite the promising growth prospects in the blood irradiation indicators and labels market, several threats could impact its trajectory. The rapid pace of technological advancements creates a challenging environment for market players to stay competitive. Companies that fail to keep up with new developments risk losing market position to more innovative competitors. Additionally, stringent regulatory compliance and the potential for changes in regulations can pose significant challenges, especially for smaller companies lacking the resources to navigate complex regulatory landscapes. Moreover, the ongoing global economic uncertainties may lead to budget constraints within healthcare institutions, impacting their willingness to invest in new technologies and solutions.

Furthermore, the emergence of alternative blood safety solutions, such as molecular diagnostic testing, could pose a threat to the traditional blood irradiation indicators and labels market. As new technologies develop, healthcare providers may opt for solutions perceived to offer higher efficacy or lower costs. This shift could lead to a decrease in demand for existing products, challenging market players to innovate continually to maintain relevance. The potential for market saturation in developed regions may also create obstacles for companies seeking to expand their presence, necessitating a focused approach to market differentiation and strategic positioning.

Competitor Outlook

• 3M Company
• Becton, Dickinson and Company
• Merck KGaA
• Gibson Medical, LLC
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Ge Healthcare
• HemoSonics
• VWR International, LLC
• Siemens Healthineers
• Medtronic
• AccuBioTech Co., Ltd.
• Cardinal Health, Inc.
• CerTest Biotec S.L.
• LabCorp

The competitive landscape of the blood irradiation indicators and labels market is characterized by a mix of established players and emerging companies striving to capture market share. Leading companies are focusing on research and development initiatives to innovate and enhance their product offerings. The emphasis on developing advanced blood safety solutions has intensified competition, leading to strategic partnerships, collaborations, and acquisitions within the industry. Major players are also investing in marketing efforts to raise awareness about the importance of blood safety and the role of irradiation indicators and labels in ensuring patient safety. As technology continues to advance, companies that prioritize adaptability and responsiveness to market trends will likely gain a competitive edge.

3M Company is a prominent player in the blood irradiation indicators and labels market, known for its innovative solutions and commitment to safety. The company offers a wide range of products, including chemical and biological indicators designed to enhance blood safety in healthcare settings. 3M's focus on research and development allows it to remain at the forefront of technology, ensuring its offerings meet the evolving needs of healthcare providers. The company’s extensive distribution network and strong brand reputation further solidify its position in the market.

Thermo Fisher Scientific, Inc. is another key competitor, renowned for its comprehensive portfolio of blood safety solutions. The company leverages its expertise in scientific research to develop advanced biological indicators and irradiation monitoring technologies. Thermo Fisher's commitment to quality and innovation has earned it a significant share of the market. The company's strategic collaborations with healthcare institutions and ongoing investments in R&D bolster its competitive position, allowing it to cater effectively to the growing demand for blood irradiation solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 LabCorp
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 3M Company
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 HemoSonics
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Merck KGaA
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Ge Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 CerTest Biotec S.L.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Gibson Medical, LLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AccuBioTech Co., Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cardinal Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 VWR International, LLC
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Becton, Dickinson and Company
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Irradiation Indicators and Labels Market, By Application
    • 6.1.1 Blood Banks
    • 6.1.2 Hospitals
    • 6.1.3 Pharmaceutical Companies
    • 6.1.4 Research Institutes
    • 6.1.5 Others
  • 6.2 Blood Irradiation Indicators and Labels Market, By Product Type
    • 6.2.1 Chemical Indicators
    • 6.2.2 Biological Indicators
    • 6.2.3 Radiochromic Labels
    • 6.2.4 Thermochromic Labels
    • 6.2.5 Biological Labels
  • 6.3 Blood Irradiation Indicators and Labels Market, By Ingredient Type
    • 6.3.1 Radiation-Sensitive Materials
    • 6.3.2 Biological Materials
    • 6.3.3 Adhesive Materials
    • 6.3.4 Printing Materials
    • 6.3.5 Packaging Materials
  • 6.4 Blood Irradiation Indicators and Labels Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Hospitals/Clinics
    • 6.4.3 Specialty Stores
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Blood Irradiation Indicators and Labels Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Irradiation Indicators and Labels market is categorized based on

By Product Type

• Chemical Indicators
• Biological Indicators
• Radiochromic Labels
• Thermochromic Labels
• Biological Labels

By Application

• Blood Banks
• Hospitals
• Pharmaceutical Companies
• Research Institutes
• Others

By Distribution Channel

• Online Stores
• Hospitals/Clinics
• Specialty Stores
• Others

By Ingredient Type

• Radiation-Sensitive Materials
• Biological Materials
• Adhesive Materials
• Printing Materials
• Packaging Materials

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• 3M Company
• Becton, Dickinson and Company
• Merck KGaA
• Gibson Medical, LLC
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Ge Healthcare
• HemoSonics
• VWR International, LLC
• Siemens Healthineers
• Medtronic
• AccuBioTech Co., Ltd.
• Cardinal Health, Inc.
• CerTest Biotec S.L.
• LabCorp